Test Compendium
Test Compendium is your definitive resource for detailed information on a wide array of diagnostic tests. Each entry in our compendium is meticulously cataloged to aid healthcare providers in selecting and interpreting the right tests for their patients.
Displaying 76 - 100 of 475
Concurrent DeepSightâ„¢ Comprehensive 523 genes Liquid Biopsy (Somatic) + Neovare Portfolio testing (Germline)
MolecularConcurrent DeepSightâ„¢ Comprehensive 523 genes Liquid Biopsy (Somatic) + Neovare Portfolio testing (Germline) Methodology Molecular Test Description Disease Solid tumors; Breast cancer, Ovarian cancer,
Concurrent DeepSightâ„¢ on Liquid + siPortfolio Multi-Omicsâ„¢ on Tissue
MolecularConcurrent DeepSight™ on Liquid + siPortfolio Multi-Omics™ on Tissue Methodology Molecular Test Description Disease Solid tumorsOn Tissue: siPortfolio Multi-Omics™ • NGS (500+ genes, TMB, MSI)
LymphoSightâ„¢
LymphoSightâ„¢ Test Description Probes/Genes IHC/CISH ALK1, BCL-1, BCL-2, BCL-6, BRAF, Bob1, CD2, CD3, CD4, CD5, CD7, CD8, CD10, CD15, CD20, CD21, CD23, CD25*, CD30, CD43, CD79a, CD138, C-MYC, EBV-LMP, Granzyme B, ICOS*, IgA, IgG, IgG4, IgM, Kappa, Ki-67, Lambda, LEF1*, Mum1, OCT2, Pax5, Perforin, PD-1, TIA1. *: Pending CISH: EBER, Kappa,
Karyotyping Lymphoid - T-Cell
KaryotypingKaryotyping Lymphoid - T-Cell Methodology Karyotyping Test Description Probes/Genes - Disease Subtyping of lymphomas, leukemias and solid tumours for the purpose of exact diagnosis, treatment stratification
Karyotyping Lymphoid - B-Cell
KaryotypingKaryotyping Lymphoid - B-Cell Methodology Karyotyping Test Description Probes/Genes - Disease Subtyping of lymphomas, leukemias and solid tumours for the purpose of exact diagnosis, treatment stratification
Pan-Lymphoid Multi gene panel
MolecularPan-Lymphoid Multi gene panel Methodology Molecular Test Description Genes (17 Genes) : ATM (exons 2-63), BIRC3 (exons 6-8), BTK (exons14-16), CARD11 (exons 2-8), CD79B (exons 4-5), DDX3X (exons 7-9,11,14),
JAK2 V617F reflex to CALR, MPL & > 65 genes NGS panel
MolecularJAK2 V617F reflex to CALR, MPL & > 65 genes NGS panel Methodology Molecular Test Description Genes (69 Genes) : ABL Kinase, ASXL1, BCOR, BRAF, CALR, CBL, CEBPA, CSF3R, DNMT3A, ETV6, EZH2, FLT3,
NGS–AML Panel
MolecularNGS–AML Panel Methodology Molecular Test Description Genes (69 Genes) : ABL Kinase, ASXL1, BCOR, BRAF, CALR, CBL, CEBPA, CSF3R, DNMT3A, ETV6, EZH2, FLT3, GATA2, HRAS, IDH1, IDH2, IKZF1, JAK2, KIT, KRAS,
NGS–CMML Panel
MolecularNGS–CMML Panel Methodology Molecular Test Description Genes (69 Genes) : ABL Kinase, ASXL1, BCOR, BRAF, CALR, CBL, CEBPA, CSF3R, DNMT3A, ETV6, EZH2, FLT3, GATA2, HRAS, IDH1, IDH2, IKZF1, JAK2, KIT, KRAS,
NGS-MDS Panel
MolecularNGS-MDS Panel Methodology Molecular Test Description Genes (69 Genes) : ABL Kinase, ASXL1, BCOR, BRAF, CALR, CBL, CEBPA, CSF3R, DNMT3A, ETV6, EZH2, FLT3, GATA2, HRAS, IDH1, IDH2, IKZF1, JAK2, KIT, KRAS,
NGS-MPN Panel
MolecularNGS-MPN Panel Methodology Molecular Test Description Genes (69 Genes) : ABL Kinase, ASXL1, BCOR, BRAF, CALR, CBL, CEBPA, CSF3R, DNMT3A, ETV6, EZH2, FLT3, GATA2, HRAS, IDH1, IDH2, IKZF1, JAK2, KIT, KRAS,
Pan-Myeloid Multi gene Panel
MolecularPan-Myeloid Multi gene Panel Methodology Molecular Test Description Genes (69 Genes) : ABL Kinase, ASXL1, BCOR, BRAF, CALR, CBL, CEBPA, CSF3R, DNMT3A, ETV6, EZH2, FLT3, GATA2, HRAS, IDH1, IDH2, IKZF1,
MLL Single Gene
MolecularMLL Single Gene Methodology Molecular Test Description Genes (MLL) Disease Acute Myeloid Leukemia & Acute Lymphoblastic LeukemiaNext generation sequencing of gene panel. The MLL complex plays a crucial
KRAS Mutation Analysis
MolecularKRAS Mutation Analysis Alternative Name KRAS Exons 2-4 (includes G12C mutation) Methodology Molecular Test Description Genes KRAS variants in exon 2 (eg, codons 12 and 13) & additional variant(s) (eg,
ABL1 Fusion
MolecularABL1 Fusion Methodology Molecular Test Description Genes ABL1 Disease Chronic myeloid Leukemia, B-cell acute lymphoblastic leukemia and very rarely in acute myeloid leukemia.Next generation sequencing
ABL Kinase Mutation
MolecularABL Kinase Mutation Methodology Molecular Test Description Genes ABL1 Kinase Disease Chronic Myeloid Leukemia, B-cell acute lymphoblastic leukemia and very rarely in acute myeloid leukemia.Mutations in
AKT1 single gene test
MolecularAKT1 single gene test Methodology Molecular Test Description Genes AKT1 Disease breast invasive ductal carcinoma, colon adenocarcinoma, endometrial endometrioid adenocarcinoma, lung adenocarcinoma,Molecular
AKT3 single gene test
MolecularAKT3 single gene test Methodology Molecular Test Description Genes AKT3 Disease lung adenocarcinoma, breast invasive ductal carcinoma, colon adenocarcinoma, endometrial endometrioid adenocarcinoma, and
ALK fusion
MolecularALK fusion Methodology Molecular Test Description Genes ALK Disease Anaplastic large cell lymphomas, Neuroblastoma, and Non-small cell lung cancerNext generation sequencing of gene panel. This gene encodes
ALK Mutation Analysis
MolecularALK Mutation Analysis Methodology Molecular Test Description Genes ALK Disease Anaplastic large cell lymphomas, Neuroblastoma, and Non-small cell lung cancerMolecular test that utilizes NGS technology
Neovare Comprehensive Risk Assessment Panel (Germline)
MolecularNeovare Comprehensive Risk Assessment Panel (Germline) Alternative Name NGS–Comprehensive HCP (Hereditary Cancer Panel) Methodology Molecular Test Description Genes APC, ATM, AXIN2, BAP1, BARD1, BRCA1,
Pancreatic Cancer Risk Assesment Panel (Germline)
MolecularPancreatic Cancer Risk Assesment Panel (Germline) Alternative Name NGS–Pancreatic Cancer HCP (Hereditary Cancer Panel) Methodology Molecular Test Description Genes APC, ATM, BMPR1A, BRCA1, BRCA2, CDK4,
Lynch Syndrome & Hereditary Colon Cancer Risk Assessment Panel (Germline)
MolecularLynch Syndrome & Hereditary Colon Cancer Risk Assessment Panel (Germline) Alternative Name NGS–Lynch/Colon Cancer HCP (Hereditary Cancer Panel) Methodology Molecular Test Description Genes APC, CHEK2,
Androgen Receptor
MolecularAndrogen Receptor Alternative Name AR Mutation Analysis Methodology Molecular Test Description Genes AR Disease Prostate cancer, invasive breast cancers, Polycystic Ovary Syndrome (PCOS), Androgen Insensitivity,
ASXL1
MolecularASXL1 Methodology Molecular Test Description Genes ASXL1 Disease myelodysplastic neoplasm, Chronic Myelomonocytic Leukemia, Acute myeloid leukemia (AML), Systemic mastocytosis, Bohring-Opitz syndromeNext
ATM
MolecularATM Methodology Molecular Test Description Genes ATM (exons 2-63) Disease CLL (of prognostic value for FCR treatment response), endometrial cancer, bladder cancer, melanoma, intestinal cancer, and stomach
Hereditary Breast and Ovarian Cancer Risk Assessment Panel (Germline)
MolecularHereditary Breast and Ovarian Cancer Risk Assessment Panel (Germline) Alternative Name NGS–Breast/Ovary Cancer HCP (Hereditary Cancer Panel) Methodology Molecular Test Description Genes ATM, BARD1, BRCA1,
Hereditary Prostate cancer Risk Assessment Panel (Germline)
MolecularHereditary Prostate cancer Risk Assessment Panel (Germline) Alternative Name NGS–Prostate Cancer HCP (Hereditary Cancer Panel) Methodology Molecular Test Description Genes ATM, BRCA1, BRCA2, CHEK2, EPCAM,
